Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Recently, new advances were made regarding the depletion of CD45RA naïve T cells from haploidentical grafts as they are suspected to be the most alloreactive.

Methods: Within this project we investigated CD45RA-depletion from G-CSF mobilized PBSC by two different purification strategies according to GMP, specifically direct depletion of CD45RA cells (one-step approach), or CD34-positive selection followed by CD45RA-depletion (two-step approach).

Results: With log -3.9 and - 3.8 the depletion quality of CD45RA T cells was equally for both approaches together with a close to complete CD19 B cell depletion. However, due to a high expression of CD45RA the majority of NK cells were lost within both CD45RA depletion strategies. Stem cell recovery after one-step CD45RA-depletion was at median 52.0% (range: 49.7-67.2%), which was comparable to previously published recovery data received from direct CD34 positive selection. Memory T cell recovery including CD4 and CD8 memory T cell subsets was statistically not differing between both purification approaches. The recovery of CD4 and CD8 T cells was as well similar, but overall a higher amount of cytotoxic than T-helper cells were lost as indicated by an increase of the CD4/CD8 ratio.

Conclusions: CD45RA-depletion from G-CSF mobilized PBSC is feasible as one- and two-step approach and results in sufficient reduction of CD45RA T cells as well as B cells, but also to a co-depletion of NK cells. However, by gaining two independent cell products, the two-step approach enables the highest clinical flexibility in regard to individual graft composition with precise dosage of stem cells and T cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2021.112960DOI Listing

Publication Analysis

Top Keywords

cd45ra cells
16
depletion cd45ra
12
cells
12
cd45ra-depletion g-csf
8
g-csf mobilized
8
mobilized pbsc
8
cells lost
8
cell recovery
8
memory cell
8
cd4 cd8
8

Similar Publications

Objective: Major depressive disorder (MDD) is among the most prevalent and debilitating mental health conditions worldwide. This study aims to investigate the bidirectional causal relationship between immune cells and MDD using Mendelian randomization (MR) analysis and determine whether metabolites mediate this relationship.

Methods: We compiled and analyzed whole-genome data for 731 immune cell traits, 1091 blood metabolites, 309 metabolic ratios, and disease data from 170,756 individuals with MDD and 329,443 controls.

View Article and Find Full Text PDF

T-cell receptor repertoire and HLA in osteoarthritis: A systematic literature review.

Osteoarthritis Cartilage

September 2025

Immunology, Immunopathology, Immunotherapy I3 Lab, Inserm UMRS 959, Sorbonne Université, Paris, France; Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Electronic address: encarnita.mariotti@sorbonne-u

Objective: The aim of this systematic literature review was to provide a comprehensive overview of T-Cell Receptor (TCR) mediated immunity research in osteoarthritis (OA).

Design: The search was conducted in April 2024 on PubMed and Embase, following PRISMA 2020. Search was primarily based on MeSH terms, free-text was used when required.

View Article and Find Full Text PDF

PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity.

Sci Adv

September 2025

Department of Medicine, Altman Clinical and Translational Research Institute, University of California, San Diego, La Jolla, CA 92093, USA.

Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is encoded by a gene strongly associated with lupus and other autoimmune diseases. PTPN22 regulates T cell receptor (TCR) signaling through dephosphorylation of the kinases lymphocyte-specific protein tyrosine kinase (LCK) and zeta-chain-associated protein kinase 70 (ZAP70). The regulation of PTPN22 remains poorly understood.

View Article and Find Full Text PDF

A single-cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesis.

Cell Rep

September 2025

Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA; Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA

Hematopoietic multipotent progenitors (MPPs) regulate blood cell production to meet the evolving demands of an organism. Adult human MPPs remain ill defined, whereas mouse MPPs are well characterized, with distinct immunophenotypes and lineage potencies. Using multi-omic single-cell analyses and functional assays, we identified distinct human MPPs within Lin-CD34+CD38dim/lo adult bone marrow with unique biomolecular and functional properties.

View Article and Find Full Text PDF

Coronary artery disease (CAD), tuberculosis (TB), and HIV represent major global health burdens. Individuals affected by one or more of these conditions often exhibit chronic inflammation and immune dysregulation, with monocytes playing a central role in these processes. Monocyte subsets are known to expand in individuals with HIV, TB, or CAD.

View Article and Find Full Text PDF